Life Molecular Imaging
Mathias Berndt has over 17 years of experience in the pharmaceutical industry with a focus on radiopharmaceutical discovery and development. Mathias has held various leadership positions, including VP Chemical R&D and Manufacturing at Life Molecular Imaging since 2018, where they are responsible for managing manufacturing, network expansion, and technical development of new radiopharmaceuticals. Prior to this, they worked as the Sr. Director Chemical R&D at Piramal Enterprises Limited from 2012 to 2018 and Global Drug Discovery, Radiopharmaceutical and Medicinal Chemistry at Bayer HealthCare from 2006 to 2012. Mathias started their career as a Research Associate at Helmholtz-zentrum Dresden-Rossendorf from 2004 to 2006, focusing on PET probe development and labeling methods.
Mathias Berndt completed their education with two degrees. From 1994 to 1999, they attended Technische Universität Dresden, where they obtained a Diploma in Chemistry. Following this, from 1999 to 2003, they pursued their studies at Freie Universität Berlin and achieved a Dr.rer.nat. in Organic Chemistry.
This person is not in any offices
Life Molecular Imaging
Life Molecular Imaging (formerly Piramal Imaging) is now part of the Alliance Medical Group, an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. These combined services allow physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine. With an ever increasing demand of effective care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity for: - Earlier detection and better characterization of diseases - Determining the right therapy at the right dose for a patient (precision medicine) - Monitoring therapy response As a global leader in the field of radiopharmaceuticals, Life Molecular Imaging is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology. Life Molecular Imaging is supporting use of imaging biomarkers in several major therapeutic trials in Alzheimer’s disease. Imprint: Life Molecular Imaging GmbH Tegeler Strasse 6-7 13353 Berlin Germany Telefon: +49 30 461 124603 Fax: +49 30 461 124 629 Email: info@life-mi.com Internet: http://www.life-mi.com Managing Directors: Dr. Ludger Dinkelborg Michel Jongens Chamber of Commerce: Amtsgericht Charlottenburg HRB 136823 B Sales tax identification number: DE 283685037 Data Protection Policy: https://life-mi.com/data-protection/